Myszkowski Kenneth Allen

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$26,700.00
Insider Sells Quantity
27
Insider Sells Sum
$26.26M

Insider Activity of Myszkowski Kenneth Allen

According to the SEC Form 4 filings, Myszkowski Kenneth Allen, being in a position of

  1. Chief Financial Officer at Arrowhead Pharmaceuticals, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 56104 shares for $1.98M,
    over all time since 2010-08-27, has bought 30000 shares for $26,700, and sold 953941 share for $26.26M.

The largest purchase of all time was on 2010-08-27 and amounted to 30000 shares of Arrowhead Pharmaceuticals, Inc. for $26,700.

The largest sale of all time was on 2020-11-09 and amounted to 43505 shares of Arrowhead Pharmaceuticals, Inc. for $3.02M.

Biography of Myszkowski Kenneth Allen

No biography is available at this moment.

2024-03-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
40,000
0.0323%
$35.19$1.41M-32.51%
2024-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
16,104
0.0148%
$35.27$567,910-30.44%
2023-06-27SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
15,000
0.0141%
$36.20$543,000-22.38%
2022-12-29SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
30,625
0.0288%
$40.00$1.23M-24.15%
2022-01-05SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
40,000
0.0389%
$61.70$2.47M-34.2%
2021-01-12SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
1,441
0.0014%
$81.00$116,721-17.38%
2021-01-11SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
11,597
0.0113%
$81.02$939,589-14.65%
2021-01-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
30,625
0.0287%
$72.44$2.22M-7.92%
2020-11-09SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
43,505
0.0431%
$69.37$3.02M+0.95%
2020-10-20SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
29,166
0.028%
$54.04$1.58M+24.84%
2020-01-21SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
40,313
0.0412%
$49.44$1.99M-9.52%
2020-01-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
20,000
0.0199%
$60.11$1.2M-27.55%
2019-11-01SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
37,884
0.0384%
$40.85$1.55M+2.7%
2019-05-21SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
27,071
0.0294%
$22.00$595,562+60.05%
2019-02-19SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
8,000
0.0084%
$18.00$144,000+61.09%
2019-01-17SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
163,750
0.173%
$14.55$2.38M+92.41%
2019-01-02SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
16,666
0.0162%
$11.98$199,659+107.74%
2018-09-06SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
90,000
0.0768%
$15.07$1.36M-4.18%
2018-06-19SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
40,000
0.0261%
$8.01$320,400+14.98%
2018-05-31SaleArrowhead Pharmaceuticals, Inc.
ARWR
Chief Financial Officer
25,200
0.0295%
$11.00$277,200+41.7%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.